Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents

Timo Vesikari; York LauraJ; John L Perez; Wysocki Jacek; Beeslaar Johannes; Joseph Eiden; Jiang Qin; Kathrin U Jansen; Thomas R Jones; Shannon L Harris; Robert E O'Neill

doi:10.1093/jpids/piv064

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents

Timo Vesikari
, York LauraJ
, John L Perez
, Wysocki Jacek
, Beeslaar Johannes
, Joseph Eiden
, Jiang Qin
, Kathrin U Jansen
, Thomas R Jones
, Shannon L Harris
, Robert E O'Neill

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

40 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	180-7
Julkaisu	Journal of the Pediatric Infectious Diseases Society
Vuosikerta	5
Numero	2
DOI - pysyväislinkit	https://doi.org/10.1093/jpids/piv064
Tila	Julkaistu - 2016
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

SDG 3 – Hyvä terveys ja hyvinvointi

Julkaisufoorumi-taso

Jufo-taso 0

Pääsy asiakirjaan

10.1093/jpids/piv064

Siteeraa tätä

Vesikari, T., LauraJ, Y., Perez, J. L., Jacek, W., Johannes, B., Eiden, J., Qin, J., Jansen, K. U., Jones, T. R., Harris, S. L., & O'Neill, R. E. (2016). Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents. Journal of the Pediatric Infectious Diseases Society, 5(2), 180-7. https://doi.org/10.1093/jpids/piv064

Vesikari, Timo ; LauraJ, York ; Perez, John L et al. / Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents. Julkaisussa: Journal of the Pediatric Infectious Diseases Society. 2016 ; Vuosikerta 5, Nro 2. Sivut 180-7.

@article{9122cde396864f9287200c8d09c6c8af,

title = "Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents",

author = "Timo Vesikari and York LauraJ and Perez, \{John L\} and Wysocki Jacek and Beeslaar Johannes and Joseph Eiden and Jiang Qin and Jansen, \{Kathrin U\} and Jones, \{Thomas R\} and Harris, \{Shannon L\} and O'Neill, \{Robert E\}",

year = "2016",

doi = "10.1093/jpids/piv064",

language = "English",

volume = "5",

pages = "180--7",

journal = "Journal of the Pediatric Infectious Diseases Society",

issn = "2048-7193",

publisher = "Oxford University Press",

number = "2",

}

Vesikari, T, LauraJ, Y, Perez, JL, Jacek, W, Johannes, B, Eiden, J, Qin, J, Jansen, KU, Jones, TR, Harris, SL & O'Neill, RE 2016, 'Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents', Journal of the Pediatric Infectious Diseases Society, Vuosikerta 5, Nro 2, Sivut 180-7. https://doi.org/10.1093/jpids/piv064

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents. / Vesikari, Timo; LauraJ, York; Perez, John L et al.
julkaisussa: Journal of the Pediatric Infectious Diseases Society, Vuosikerta 5, Nro 2, 2016, s. 180-7.

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents

AU - Vesikari, Timo

AU - LauraJ, York

AU - Perez, John L

AU - Jacek, Wysocki

AU - Johannes, Beeslaar

AU - Eiden, Joseph

AU - Qin, Jiang

AU - Jansen, Kathrin U

AU - Jones, Thomas R

AU - Harris, Shannon L

AU - O'Neill, Robert E

PY - 2016

Y1 - 2016

U2 - 10.1093/jpids/piv064

DO - 10.1093/jpids/piv064

M3 - Article

SN - 2048-7193

VL - 5

SP - 180

EP - 187

JO - Journal of the Pediatric Infectious Diseases Society

JF - Journal of the Pediatric Infectious Diseases Society

IS - 2

ER -

Vesikari T, LauraJ Y, Perez JL, Jacek W, Johannes B, Eiden J et al. Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents. Journal of the Pediatric Infectious Diseases Society. 2016;5(2):180-7. doi: 10.1093/jpids/piv064